Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 1/20 | 0.61 |
| ▸ | CA12 | O43570 | 6/20 | 0.36 |
| ▸ | CA1 | P00915 | 6/20 | 0.36 |
| ▸ | CA9 | Q16790 | 6/20 | 0.36 |
| ▸ | CA2 | P00918 | 5/20 | 0.36 |
| ▸ | PRKCA | P17252 | 4/20 | 0.36 |
| ▸ | CCR4 | P51679 | 1/20 | 0.33 |
| ▸ | HAT1 | O14929 | 2/20 | 0.32 |
| ▸ | EP300 | Q09472 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | PRKCB | P05771 | 1/20 | 0.31 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.31 |
| ▸ | DUT | P33316 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10122112 | 0.93 | GHSR (0.64) | GHSRCA12CA1CA9CA2 | |
| SCHEMBL1709644 | 0.89 | GHSR (0.62) | GHSRCA12CA1CA9CA2 | |
| SCHEMBL1709541 | 0.87 | GHSR (0.61) | GHSRPRKCACCR4MEN1KMT2A | |
| SCHEMBL10121677 | 0.83 | GHSR (0.71) | GHSRCA12CA1CA9CA2 | |
| SCHEMBL10121929 | 0.83 | GHSR (0.70) | GHSRCA12CA1CA9CA2 | |
| SCHEMBL10121669 | 0.82 | GHSR (0.61) | GHSRKMT2ADUT | |
| SCHEMBL10122110 | 0.82 | GHSR (0.71) | GHSRMEN1KMT2A | |
| SCHEMBL1988787 | 0.81 | GHSR (0.67) | GHSRCCR4MEN1KMT2A | |
| SCHEMBL1986948 | 0.80 | GHSR (0.71) | GHSRCCR4GAA | |
| SCHEMBL1988279 | 0.80 | GHSR (0.68) | GHSRCCR4HAT1EP300MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120088747-A1 | SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF | ELIXIR PHARMACEUTICALS, INC. | 2012-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088747-A1 | SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF | GHSR, GHRHR, STS | GHSR 1/4885CA12 613/4885CA1 1399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.